ArticleBrain : a journal of neurology2022

Gene therapy targeting the blood-brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency.

Sivaraj M Sundaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.